CALLEGARI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 4.204
AS - Asia 1.883
EU - Europa 1.332
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 44
OC - Oceania 3
Totale 7.820
Nazione #
US - Stati Uniti d'America 4.081
SG - Singapore 698
CN - Cina 465
IT - Italia 350
DE - Germania 237
VN - Vietnam 212
BR - Brasile 184
PL - Polonia 165
HK - Hong Kong 137
GB - Regno Unito 113
UA - Ucraina 100
BD - Bangladesh 99
FI - Finlandia 98
TR - Turchia 64
CA - Canada 63
FR - Francia 51
ID - Indonesia 45
RU - Federazione Russa 38
IN - India 37
MX - Messico 37
JP - Giappone 35
SE - Svezia 35
AR - Argentina 25
NL - Olanda 22
RO - Romania 22
ES - Italia 19
CZ - Repubblica Ceca 16
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 12
PK - Pakistan 12
CO - Colombia 9
LT - Lituania 9
UZ - Uzbekistan 9
VE - Venezuela 9
BE - Belgio 8
GR - Grecia 8
OM - Oman 7
EG - Egitto 6
IE - Irlanda 6
IR - Iran 6
KE - Kenya 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
JM - Giamaica 5
KR - Corea 5
SA - Arabia Saudita 5
BO - Bolivia 4
HU - Ungheria 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
HN - Honduras 3
JO - Giordania 3
NP - Nepal 3
PA - Panama 3
SV - El Salvador 3
AM - Armenia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
HR - Croazia 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 7.712
Città #
Ashburn 516
Fairfield 456
Singapore 431
San Jose 356
Woodbridge 260
Houston 217
Warsaw 164
Seattle 163
Beijing 158
Wilmington 149
Chandler 144
Munich 141
Ann Arbor 139
Santa Clara 137
Cambridge 135
Hong Kong 132
Jacksonville 110
Council Bluffs 92
New York 92
Ferrara 81
Los Angeles 74
Ho Chi Minh City 67
Helsinki 53
Milan 48
Dallas 46
Hanoi 41
Nanjing 41
Izmir 39
Jakarta 37
Shanghai 36
San Diego 35
Tokyo 35
Princeton 33
Bologna 31
Lauterbourg 31
London 29
Boardman 25
Rome 25
São Paulo 23
Nanchang 20
Chicago 19
Jinan 18
Mexico City 18
Montreal 18
Turku 18
Orem 17
Timisoara 17
Atlanta 16
Toronto 16
Turin 16
Buffalo 14
Brno 13
Phoenix 13
Denver 12
Nuremberg 11
San Francisco 11
Addison 10
Boston 10
Brooklyn 10
Dearborn 10
Manchester 10
Moscow 10
Shenyang 10
The Dalles 10
Da Nang 9
Frankfurt am Main 9
Hangzhou 9
Hefei 9
Washington 9
Belo Horizonte 8
Dong Ket 8
Falls Church 8
Haiphong 8
Johannesburg 8
Mountain View 8
Stockholm 8
Tampa 7
Tashkent 7
Vancouver 7
Brussels 6
Changsha 6
Dublin 6
Düsseldorf 6
Hebei 6
Querétaro 6
Ankara 5
Auburn Hills 5
Berkeley 5
Chennai 5
Des Moines 5
Guangzhou 5
Hyderabad 5
Jiaxing 5
Kunming 5
Lancaster 5
Leeds 5
Miami 5
Ningbo 5
North Bergen 5
Norwalk 5
Totale 5.402
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 412
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 310
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 304
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 270
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 263
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 254
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 250
MicroRNA involvement in hepatocellular carcinoma 244
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 243
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 236
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 230
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 225
Animal Models of Hepatocellular Carcinoma Prevention 224
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 224
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 219
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma 217
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 212
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 209
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 204
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 200
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 199
MicroRNA response to environmental mutagens in liver 199
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 197
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 192
Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients 191
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 178
MicroRNAs in Animal Models of HCC 167
Novel Virus Identification through Metagenomics: A Systematic Review 157
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 144
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 139
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 134
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 122
null 107
null 103
null 89
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 78
Role of microRNAs in hepatocellular carcinoma: a clinical perspective 65
null 63
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 42
Totale 7.820
Categoria #
all - tutte 32.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022348 0 0 52 18 10 29 22 22 17 25 40 113
2022/2023344 32 19 19 46 47 42 40 25 41 0 21 12
2023/2024305 15 35 15 6 21 77 11 39 6 6 7 67
2024/20251.183 30 25 77 35 121 143 61 63 235 114 139 140
2025/20262.855 301 67 189 290 414 176 420 167 275 283 181 92
2026/2027275 64 149 62 0 0 0 0 0 0 0 0 0
Totale 7.820